Abstract:Pharmacological regulation of Toll-like receptor (TLR) responses holds great promise in the treatment of many inflammatory diseases. However, there have been limited compounds available so far to attenuate TLR signaling and there have been no clinically approved TLR inhibitors (except the anti-malarial drug hydroxychloroquine) in clinical use. In light of rapid advances in nanotechnology, manipulation of immune responsiveness using nano-devices may provide a new strategy to treat these diseases. Herein, we present a high throughput screening method for quickly identifying novel bioactive nanoparticles that inhibit TLR signaling in phagocytic immune cells. This screening platform is built on THP-1 cell-based reporter cells with colorimetric and luciferase assays. The reporter cells are engineered from the human THP-1 monocytic cell line by stable integration of two inducible reporter constructs. One expresses a secreted embryonic alkaline phosphatase (SEAP) gene under the control of a promoter inducible by the transcription factors NF-κB and AP-1, and the other expresses a secreted luciferase reporter gene under the control of promoters inducible by interferon regulatory factors (IRFs).Upon TLR stimulation, the reporter cells activate transcription factors and subsequently produce SEAP and/or luciferase, which can be detected using their corresponding substrate reagents. Using a library of peptide-gold nanoparticle (GNP) hybrids established in our previous studies as an example, we identified one peptide-GNP hybrid that could effectively inhibit the two arms of TLR4 signaling cascade triggered by its prototypical ligand, lipopolysaccharide (LPS). The findings were validated by standard biochemical techniques including immunoblotting. Further analysis established that this lead hybrid had a broad inhibitory spectrum, acting on multiple TLR pathways, including TLR2, 3, 4, and 5. This experimental approach allows a rapid assessment of whether a nanoparticle (or other therapeutic compounds) can modulate specific TLR signaling in phagocytic immune cells.

Screening And Identification Of Proteins Interacted With Cytoplasmic Fragment Of Human Toll Like Receptor 4 Using T7 Select Phage Display System

Identification of Human T Cell Receptor Γδ-Recognized Epitopes/Proteins Via CDR3δ Peptide-based Immunobiochemical Strategy

Comprehensive RNAi-based screening of human and mouse TLR pathways identifies species-specific preferences in signaling protein use.

Functional Identification of the Stable Transfection C5ar Cell Line Molt-4

Screening of Proteins Binding with Human CD8+T Lymphocytes with T7 Select Human Hepatoma cDNA Library

Screening and Identification of TNF-α Binding Peptide and TNFR Blocking Peptide

Screening TLR4 Binding Peptide from Naja atra Venom Glands based on Phage Display

A Human Anti-Toll Like Receptor 4 Fab Fragment Inhibits Lipopolysaccharide-Induced Pro-Inflammatory Cytokines Production in Macrophages.

Prokaryotic Expression and Binding Activity of Different Extracellular Fragments of Human TLR-2

Massively Parallel Screening of Toll/Interleukin‐1 Receptor (TIR)‐Derived Peptides Reveals Multiple Toll‐Like Receptors (TLRs)‐Targeting Immunomodulatory Peptides

PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene

Screening and identification of a novel transferrin receptor binding peptide

Natural Triterpenoid-Aided Identification of the Druggable Interface of HMGB1 Occupied by TLR4

Quantitative Proteomics Identified TTC4 As a TBK1 Interactor and a Positive Regulator of SeV‐Induced Innate Immunity

Massively parallel screening of TIR-derived peptides reveals vast TLR-targeting immunomodulatory peptides

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling.

Identification of atypical T4SS effector proteins mediating bacterial defense

Select Targeting of Intracellular Toll-interleukin-1 Receptor Resistance Domains for Protection Against Influenza-Induced Disease.

Toll-like receptor 4 - a multifunctional virus recognition receptor

Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex

Identification of a positively 5' regulatory region in human Toll like receptor 4 gene